record #135780702307007 | th | 47083777 | | 9715623 | 6/9/2006 12:00:00 am | pulmonary emoblism | | dis | admission date: 6/9/2006 report status:discharge date: 9/18/2006 final discharge orders dellum , ernie 785-46-99-2lisservice: meddischarge patient on: 9/11/06 at 02:00 pmcontingent upon attending evaluationwill d/c order be used as the d/c summary: yesattending: thwaites , ellsworth bert , m.d.code status:full codedisposition: rehabilitationdischarge medications:tylenol ( acetaminophen ) 650 mg po q4h prn headachedulcolax ( bisacodyl ) 5-10 mg po daily prn constipationcolace ( docusate sodium ) 100 mg po bidnexium ( esomeprazole ) 20 mg po dailyfluticasone nasal spray 2 spray inh bidadvair diskus 500/50 ( fluticasone propionate/... )1 puff inh bidfondaparinux 7.5 mg sc dailyalert overridden: override added on 6/18/06 byhalston , dewitt r. , m.d.serious interaction: heparin &amp; fondaparinux sodiumreason for override: awaresingulair ( montelukast ) 10 mg po bedtimenortriptyline hcl 10 mg po bedtimesimvastatin 40 mg po bedtimefood/drug interaction instructionavoid grapefruit unless md instructs otherwise.override notice: override added on 3/13/06 by seiters , dorian t. , m.d. on order for coumadin po ( ref # 993947515 )potentially serious interaction: simvastatin &amp; warfarinreason for override: awarecoumadin ( warfarin sodium ) 7 mg po qpmstarting now ( 1/5 )instructions: within hour of pharmacy approvalfood/drug interaction instructionno high vitamin-k containing foodsalert overridden: override added on 3/13/06 bylarison , jack l. , m.d.potentially serious interaction: simvastatin &amp; warfarinreason for override: awarediet: house / low chol/low sat. fatactivity: weight bearing as toleratedfollow up appointment( s ):dr. banwarth ,arrange inr to be drawn on 9/11/06 with f/u inr's to be drawn every1 days. inr's will be followed by rehab centerallergy: lisinopril , aspirin , nsaidsadmit diagnosis:pulmonary embolismprincipal discharge diagnosis ;responsible after study for causing admission )pulmonary emoblismother diagnosis;conditions , infections , complications , affecting treatment/stayhtn ( hypertension ) asthma ( asthma ) arthritis( arthritis ) hypercholesterol ( elevated cholesterol ) gerd( gastroesophageal reflux disease ) obese( obesity ) knee repair ( knee surgery )operations and procedures:chest ctother treatments/procedures ( not in o.r. )nonebrief resume of hospital course:cc: sob/large rt main pehpi: 62yo f w/htn , asthma , recent s/p l total knee replacementpresents with sob. today she c/o pain in the chest with deepinspiration and coughing. she also reports pain in the right leg. ptunderwent surgery on 4/10 and had routine post-op course. ofnote , pt only received routine peri-operative prophylactic abx. ptwas d/c home on 6/26 and did well for a few days. she was readmittedfor gastroenteritis 11/20 and sent home without abx. shehas been followed by vna and home pt. her coumadin was stopped0/5 after 3 weeks post-op however her inrs had not beentherapeutic.-------------------ros: denies fevers. continues to have nausea , vomiting and diarrahea.but difficult to fully assess b/c entire ros positive per patient.mostly c/o pleuritic left cp , and bilateral lepain.-------------------ed course: pect positive for pe and dvt. started on heparin.-----pmh: htn , asthma-no intub , past hosp x2 , oa-s/p lknee surg , hypercholestrolemia , gerd , cervical and thoracic disc dz ,fibromyalgia , obesity-----meds: cozaar 100mgqd nortriptyline 10mgqhs hctz 25mgqd atenolol 75qd lipitor 40mgqd singular 10mgqhs albuterol inhprn advair 250/50bid fluticasone nasal spraybid prilosec 20mgqd coumadin 3mgqd morphine 30mg q12hrprn hydromorphone 2-6mg q4-6hr prn-----all: lisinopril ( cough ) , asa ( sob ) , nsaids ( gi ) fh: ? h/o clot in hermother sh: tob: none. etoh: none. ivdu: none-----exam: 98 83 172/92 18 93%ra , 100%fm nad , aaox3. non-icteric , mmm. supple. cta( b ) withdecreased bs on the rll no wheezes , rrr , nl s1 s2. soft , obese bs ,ext: nontender , no palpable cords , no edema , 2+ ( b ) pedal pulses.left leg - ted stocking and tkr bandages.-----pect 6/1 rt main pulm artery pe extending intolovar and subsegmental arteries. small pe lll subsegmentalvessels. rt dvt le. ekg 6/1 nsr , no rvh , normal axis , normalintervals , no s1q3t3-----hospital course:62yo f with htn , asthma and recent l total knee replacementpresented with extensive pe. she was extremely sob and c/o pleuriticchest pain. her ekg and exam were not suggestive of cardiacdysfunction. cardiac enzymes were negative. the patient was initiallyanticoagulated with heparin. however , her platelets were noted to dropfrom 237 to 93. hit was suspected and heparin was discontinued. thepatient was started on fondaparinux. a pf4 antibody was sent and pendingat the time of discharge. coumadin was started after one day offondaparinux with an intent to bridge over at least 5 days with a goalinr of 2-3. the patient's blood pressure was decreased over the course ofher admission. all antihypertensives were held. she may be preloaddependent in the setting of an acute pe. during her admission anechocardiogram was performed. it did not show evidence of right heartstrain or lv dysfunction. her ef was 65-70%. over the course of thehospitalzation , the patient's symptoms improved dramatically. her oxygenrequirement decreased. her vital signs remained stable.the patients respiratory status remained stable on home regimentof inhalers and nebulizers prn.ortho evaluated the patient while hospitalized and recommended weightbearing as tolerated. the patient did not require narcotics for painassociated with tkr.heparin products should be avoided. the pf4 antibody will need to befollowed by the pcp.full codeadditional comments: please notify your doctor of any shortness of breath or chest pain.please continue your fonduparinox and coumadin as directed.discharge condition: stableto do/plan:please bridge fondaparinux to coumadin with at least a 5 dayoverlap. please continue for at least 2 days once the patient istherpeutic on coumadin with inr 2-3. 9/11/06 is the fourth dayof fondaparinux and third day of coumadin.- monitor inr closely and platelet count.no dictated summaryentered by: lleras , jere j. , m.d. ( mp00 ) 9/11/06 @ 02 end of discharge orders [report_end]